82 related articles for article (PubMed ID: 2426566)
21. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
22. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
[TBL] [Abstract][Full Text] [Related]
23. [Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Okuda T; Onda M; Tokunaga A; Teramoto T; Fujita I; Mizutani T; Kiyama T; Nishi K; Okazaki S; Kyono S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2099-102. PubMed ID: 1417017
[TBL] [Abstract][Full Text] [Related]
24. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
[TBL] [Abstract][Full Text] [Related]
25. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
[TBL] [Abstract][Full Text] [Related]
26. Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Ajisaka H; Yonemura Y; Miwa K
Hepatogastroenterology; 2004; 51(57):900-5. PubMed ID: 15143943
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between expression of RB protein and prognosis of gastric cancer].
Ogawa M; Maeda K; Chung YS; Onoda N; Kato Y; Nakata B; Sowa M
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():148-50. PubMed ID: 8678558
[TBL] [Abstract][Full Text] [Related]
28. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey.
Tiberio GA; Coniglio A; Marchet A; Marrelli D; Giacopuzzi S; Baiocchi L; Roviello F; de Manzoni G; Nitti D; Giulini SM
Eur J Surg Oncol; 2009 May; 35(5):486-91. PubMed ID: 19171450
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of serum CA 125 values in patients with gastric cancers--especially correlation with peritonitis carcinomatosa].
Takahashi Y; Suga T; Mai M
Gan To Kagaku Ryoho; 1992 Jul; 19(7):975-9. PubMed ID: 1626954
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of molecular biological detection of micrometastases in gastric carcinoma].
Tsujitani S; Kaibara N
Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):741-4. PubMed ID: 11680998
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism by which peritoneal disseminated metastasis develops in gastric cancer].
Imada T; Matsumoto A
Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):593-603. PubMed ID: 3736535
[TBL] [Abstract][Full Text] [Related]
34. Factors influencing growth rate of recurrent stomach cancers as determined by analysis of serum carcinoembryonic antigen.
Takahashi Y; Mai M; Kusama S
Cancer; 1995 Mar; 75(6 Suppl):1497-502. PubMed ID: 7889481
[TBL] [Abstract][Full Text] [Related]
35. [Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR].
Sakakura C; Takemura M; Miyagawa K; Fukuda K; Shimomura K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Ueda Y; Fujiyama J; Sonoyama T; Okazaki Y; Hayashizaki Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1906-8. PubMed ID: 15553755
[TBL] [Abstract][Full Text] [Related]
36. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis.
Maehara Y; Moriguchi S; Kakeji Y; Kohnoe S; Korenaga D; Haraguchi M; Sugimachi K
Surgery; 1991 Nov; 110(5):820-3. PubMed ID: 1948650
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors of early recurrent death after a curative resection of gastric cancer.
Mikami K; Maekawa T; Shinohara T; Hoshino S; Yamauchi Y; Noritomi T; Yamashita Y
Int Surg; 2009; 94(2):144-8. PubMed ID: 20108618
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in early gastric cancer.
Kunisaki C; Shimada H; Takahashi M; Ookubo K; Moriwaki Y; Akiyama H; Nomura M
Hepatogastroenterology; 2001; 48(37):294-8. PubMed ID: 11268989
[TBL] [Abstract][Full Text] [Related]
39. Outcome of hepatic resection for metastatic gastric cancer.
Roh HR; Suh KS; Lee HJ; Yang HK; Choe KJ; Lee KU
Am Surg; 2005 Feb; 71(2):95-9. PubMed ID: 16022005
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
